Browsing Centre for Cancer Prevention by Author "Tan, WK"
Now showing items 1-4 of 4
-
861 MODELLING FROM A MULTICENTRE, PRAGMATIC, RANDOMISED CONTROLLED TRIAL IDENTIFIES THE TARGET SCREENING POPULATION AND EXPECTED YIELD FOR BARRETT'S ESOPHAGUS AND ESOPHAGEAL CANCER DIAGNOSES
Tan, WK; Maroni, R; Offman, J; Zamani, S; Di Pietro, M; O'Donovan, M; Sasieni, P; Fitzgerald, RC (Elsevier, 2024-05) -
IDEAL AGE TO SCREEN FOR BARRETT'S OESOPHAGUS AND OESOPHAGEAL ADENOCARCINOMA: MODELLING FROM THE CYTOSPONGE-BEST3 TRIAL
Tan, WK; Maroni, R; Offman, J; di Pietro, M; Honing, J; O'Donovan, M; Sasieni, P; Fitzgerald, R (2022) -
Targeted Screening for Barrett's Esophagus and Esophageal Cancer: Post Hoc Analysis From the Randomized BEST3 Trial.
Tan, WK; Maroni, R; Offman, J; Zamani, SA; BEST3 Trial Team; Sasieni, PD; Fitzgerald, RC (2024-05-06) -
Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot
Pilonis, ND; Killcoyne, S; Tan, WK; O'Donovan, M; Malhotra, S; Tripathi, M; Miremadi, A; Debiram-Beecham, I; Evans, T; Phillips, R (Elsevier, 2022-01-11)Background Endoscopic surveillance is recommended for patients with Barrett's oesophagus because, although the progression risk is low, endoscopic intervention is highly effective for high-grade dysplasia and cancer. ...